Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

IL-4 in tuberculosis: implications for vaccine design.

Graham A W Rook1, Rogelio Hernandez-Pando, Keertan Dheda

  • 1Centre for Infectious Diseases and International Health, Windeyer Institute for Medical Sciences, Royal Free and University College Medical School, 46 Cleveland Street, London, UK. g.rook@ucl.ac.uk

Trends in Immunology
|August 25, 2004
PubMed
Summary

Current tuberculosis (TB) vaccine research assumes a Th1 response is key. However, progressive TB may stem from a detrimental Th2-like response, suggesting vaccines should suppress this activity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Kinetics of anti-SARS-CoV-2 IgG in saliva and serum post infection, and subsequent vaccination in South Africa.

African journal of laboratory medicine·2026
Same author

Performance of Human and Computer-aided Evaluation of Digital Chest Radiography for Community-based Screening of Asymptomatic Tuberculosis.

medRxiv : the preprint server for health sciences·2026
Same author

Association of linezolid interruption and rechallenge with clinical outcomes in patients with rifampicin-resistant tuberculosis in South Africa, 2018-22: an observational cohort study.

The Lancet. Global health·2026
Same author

Dendritic cells in the lung cavities of extensively drug-resistant tuberculosis patients exhibit altered frequency and phenotype.

ERJ open research·2026
Same author

Tongue swab <i>Mycobacterium tuberculosis</i> qPCR for community screening of asymptomatic TB vs. clinic-based triage of symptomatic TB.

medRxiv : the preprint server for health sciences·2026
Same author

Big Hitter in Pulmonology: Professor Christoph Lange.

African journal of thoracic and critical care medicine·2026

Area of Science:

  • Immunology
  • Vaccinology
  • Tuberculosis Research

Background:

  • Current tuberculosis (TB) vaccine development primarily targets a Th1 immune response.
  • The effectiveness of Th1-driven vaccines is questioned in the context of progressive TB disease.

Purpose of the Study:

  • To review evidence suggesting a Th2-like response, not Th1 deficiency, drives progressive TB.
  • To explore the role of interleukin-4 (IL-4) and IL-4delta2 in TB pathogenesis.
  • To propose a new strategy for TB vaccine development.

Main Methods:

  • Literature review of existing TB research.
  • Analysis of immune responses in progressive TB.
  • Evaluation of therapeutic approaches in mouse models of TB.

Related Experiment Videos

Main Results:

  • Progressive TB may be linked to an atypical Th2-like immune response involving IL-4 and IL-4delta2.
  • This response can hinder bacterial clearance and cause adverse effects like TNF-alpha toxicity and pulmonary fibrosis.
  • Pre-existing Th2-like activity may need suppression for effective vaccination.

Conclusions:

  • Effective TB vaccines may require the suppression of pre-existing Th2-like immune responses.
  • Vaccines designed to modulate this Th2-like activity show therapeutic potential in preclinical models.
  • This challenges the traditional Th1-centric approach to TB vaccine design.